DEA Schedule CII

Strength

2.5; 2.5; 2.5; 2.5 mg/1; mg/1; mg/1; mg/1

NDC

00527076237

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

4/22/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA215565

On Market Since

7/8/2022

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation

Price History

1W

0.0%

1M

-2.9%

3M

-5.9%

6M

+1.5%

1Y

-16.7%

3Y

N/A

5Y

N/A

All

-6.8%